Login / Signup

Impact of coronavirus disease 2019 monoclonal antibodies on outcomes of coronavirus disease 2019 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients.

Geetha Shanmugam
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2024)
Keyphrases
  • coronavirus disease
  • hematopoietic stem cell
  • respiratory syndrome coronavirus
  • kidney transplantation
  • type diabetes
  • stem cells
  • metabolic syndrome
  • mesenchymal stem cells
  • replacement therapy